Therapeutic Drug Monitoring of Venlafaxine and Impact of Age, Gender, BMI, and Diagnosis
, , , , , , und
18. Nov. 2020
Über diesen Artikel
Artikel-Kategorie: Original Paper
Online veröffentlicht: 18. Nov. 2020
Seitenbereich: 33 - 37
Eingereicht: 28. Feb. 2020
Akzeptiert: 24. Juni 2020
DOI: https://doi.org/10.2478/afpuc-2020-0005
Schlüsselwörter
© 2019 Krivosova M. et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Krivosova, M.
Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Kertys, M.
Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Grendar, M.
Bioinformatics Unit of Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Ondrejka, I.
Psychiatric Clinic, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Hrtanek, I.
Psychiatric Clinic, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Tonhajzerova, I.
Department of Physiology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Sekaninova, N.
Department of Physiology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia
Mokry, J.
Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Martin and University Hospital MartinMartin, Slovakia